Lactic Acid Bacteria
Mechanism of Action +
### Carbohydrate Fermentation and Environmental Acidification The primary defining biochemical characteristic of Lactic Acid Bacteria (LAB) is their ability to ferment carbohydrates into lactic acid. This process occurs via two primary metabolic pathways, dividing LAB into homofermentative and heterofermentative groups. Homofermentative LAB (such as many *Lactobacillus* species) utilize the Embden-Meyerhof-Parnas (EMP) pathway, converting hexoses almost exclusively into lactic acid. Heterofermentative LAB utilize the phosphoketolase pathway, producing a mixture of lactic acid, ethanol, acetic acid, and carbon dioxide. The continuous production of lactic acid significantly lowers the pH of the microenvironment (such as the gastrointestinal tract or the vaginal lumen). This acidic environment is fundamentally hostile to many pathogenic bacteria, including *Escherichia coli*, *Salmonella*, and *Clostridium difficile*, thereby exerting a broad-spectrum bacteriostatic effect.
### Production of Antimicrobial Compounds Beyond simple acidification, LAB synthesize and secrete a variety of potent antimicrobial compounds. The most notable of these are bacteriocins—ribosomally synthesized, extracellularly released low-molecular-weight peptides or proteins that have a bactericidal or bacteriostatic effect on other bacteria, typically closely related species. For example, *Lactobacillus acidophilus* produces lactacin B, while *Limosilactobacillus reuteri* produces reuterin (3-hydroxypropionaldehyde or 3-HPA). Reuterin is a highly potent antimicrobial agent formed during the anaerobic metabolism of glycerol, capable of inducing oxidative stress in target pathogens by depleting free thiol groups. Additionally, in the vaginal microbiome, LAB produce hydrogen peroxide (H2O2) via flavoprotein oxidases. H2O2 is highly toxic to anaerobic pathogens associated with bacterial vaginosis, as these organisms typically lack the catalase enzyme required to neutralize it.
### Competitive Exclusion and Barrier Function Enhancement LAB exert protective effects through competitive exclusion, a process by which they physically occupy adhesion sites on the mucosal epithelium, preventing the attachment and colonization of pathogenic microbes. This is mediated by surface-layer (S-layer) proteins, lipoteichoic acids, and exopolysaccharides that bind to host cell receptors. Furthermore, LAB actively enhance the integrity of the intestinal epithelial barrier. They upregulate the expression of tight junction proteins, specifically zonula occludens-1 (ZO-1), occludin, and various claudins. By fortifying these tight junctions, LAB reduce intestinal permeability (often referred to as 'leaky gut'), preventing the translocation of lipopolysaccharides (LPS) and other endotoxins from the gut lumen into the systemic circulation, thereby reducing systemic inflammation.
### Immunomodulation and the Gut-Associated Lymphoid Tissue (GALT) LAB interact intimately with the host's immune system, primarily through the Gut-Associated Lymphoid Tissue (GALT). Surface molecules of LAB, such as peptidoglycan and lipoteichoic acid, are recognized by Pattern Recognition Receptors (PRRs), specifically Toll-Like Receptors (TLR2 and TLR4), located on the surface of intestinal epithelial cells and underlying dendritic cells. This interaction triggers intracellular signaling cascades, notably the NF-κB and MAPK pathways. Depending on the specific strain of LAB, this can lead to the maturation of dendritic cells and the subsequent differentiation of naive T cells into regulatory T cells (Tregs). Tregs secrete anti-inflammatory cytokines such as Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which suppress excessive inflammatory responses and promote immune tolerance. This mechanism is particularly relevant in the management of inflammatory bowel diseases (IBD) and allergic conditions.
### Bile Salt Hydrolase Activity and Cholesterol Reduction Specific strains of LAB, such as *Lactobacillus reuteri* NCIMB 30242 (LRC™), possess high levels of the enzyme bile salt hydrolase (BSH). BSH catalyzes the deconjugation of bile acids in the intestine. Deconjugated bile acids are less efficiently reabsorbed in the terminal ileum and are subsequently excreted in the feces. To replace the lost bile acids, the liver must synthesize new ones from systemic cholesterol. This process effectively draws cholesterol out of the bloodstream, leading to a reduction in serum LDL cholesterol levels. This specific enzymatic pathway represents a highly targeted, non-pharmacological approach to lipid management.
### Pharmacokinetics and Colonization The pharmacokinetics of probiotics differ fundamentally from traditional pharmaceuticals. Upon oral ingestion, LAB must survive the harsh, highly acidic environment of the stomach and the antimicrobial action of bile salts in the duodenum. Survival rates vary drastically by strain and delivery method (e.g., microencapsulation significantly increases survival). Once in the lower intestine, LAB may either transiently colonize the mucosa or pass through the lumen. True permanent colonization is rare; most LAB are transient colonizers, meaning their physiological and immunological benefits require continuous, daily supplementation to maintain efficacious populations within the microbiome.
Is lactic acid the same as probiotic? +
What are the benefits of lactic acid bacteria capsules? +
Who should avoid taking lactic acid tablets? +
Should you take probiotics with GLP-1? +
What drugs should not be taken with probiotics? +
What are the side effects of lactic acid bacteria? +
Does Lactobacillus interact with anything? +
Is it okay to take probiotics with GLP-1? +
Do I need to refrigerate Lactic Acid Bacteria supplements? +
Can Lactic Acid Bacteria help with yeast infections? +
What is the difference between live and heat-killed probiotics? +
How long does it take for Lactic Acid Bacteria to work? +
Can I get enough Lactic Acid Bacteria from food? +
What does CFU mean on a probiotic label? +
Why did the name change from Lactobacillus to Limosilactobacillus? +
Can Lactic Acid Bacteria help with lactose intolerance? +
Everything About Lactic Acid Bacteria Article
## Introduction to Lactic Acid Bacteria (LAB)
Lactic Acid Bacteria (LAB) represent one of the most fundamentally important categories of microorganisms to human health. Naturally residing in the human mouth, stomach, intestines, lungs, vagina, and urinary tract, these beneficial bacteria are the cornerstone of a healthy microbiome. As their name suggests, LAB are characterized by their ability to ferment carbohydrates into lactic acid. This simple biochemical process has profound implications for human health, as the resulting acidic environment naturally inhibits the growth of harmful pathogens, aids in the digestion of food, and facilitates the absorption of vital nutrients.
While LAB can be found in fermented foods like yogurt, kefir, sauerkraut, and sourdough bread, they are most commonly utilized in clinical and consumer settings as dietary probiotic supplements. The most well-known members of this group belong to the *Lactobacillus* genus (recently reclassified into several new genera, including *Limosilactobacillus*), as well as *Enterococcus* and *Bifidobacterium* species.
## The Science of the Microbiome and LAB
The human body is host to trillions of microorganisms, collectively known as the microbiome. In a healthy state, there is a delicate balance between "good" bacteria (like LAB) and potentially "bad" or pathogenic bacteria. Modern lifestyles, characterized by high-sugar diets, chronic stress, and the frequent use of antibiotics, can easily disrupt this balance—a state known as dysbiosis.
When dysbiosis occurs, pathogenic bacteria can proliferate, leading to a host of issues ranging from acute digestive distress (diarrhea, constipation, bloating) to chronic systemic conditions (IBS, IBD, weakened immunity, and even mood disorders via the gut-brain axis). Supplementing with Lactic Acid Bacteria serves to re-seed the microbiome. By producing lactic acid, hydrogen peroxide, and specific antimicrobial peptides called bacteriocins, LAB actively wage war against pathogens, competitively excluding them from the mucosal lining of the gut and urogenital tracts.
## Key Strains and Their Clinical Applications
Not all Lactic Acid Bacteria are created equal. The benefits of probiotics are highly strain-specific. Understanding the specific strains is crucial for achieving desired health outcomes.
### Lactobacillus acidophilus *L. acidophilus* is perhaps the most famous of all probiotics. As noted by the Cleveland Clinic, it is heavily concentrated in the digestive and vaginal tracts. Clinically, *L. acidophilus* is primarily used to prevent and treat diarrhea, particularly diarrhea caused by a course of antibiotics. Furthermore, because it produces significant amounts of lactic acid and hydrogen peroxide, it is a frontline defense against vaginal dysbiosis, effectively treating and preventing bacterial vaginosis and vaginal yeast infections.
### Limosilactobacillus reuteri (formerly Lactobacillus reuteri) According to Examine.com's extensive database, *L. reuteri* boasts some of the strongest clinical evidence among all probiotics. * **Infantile Colic:** The strain **DSM 17938** has Grade B (Moderate Confidence) evidence for significantly reducing crying times in infants suffering from colic. It is one of the few interventions proven effective for this distressing condition. * **Cholesterol Management:** The strain **NCIMB 30242 (LRC™)** has been uniquely implicated in cardiovascular health. It produces an enzyme that breaks down bile salts in the gut, forcing the body to pull cholesterol from the blood to make more bile, thereby lowering serum LDL cholesterol. * **H. pylori Eradication:** Strains like **ATCC 55730** are used alongside traditional antibiotics to treat *Helicobacter pylori* infections, the leading cause of stomach ulcers. * **Vaginal Health:** The **RC-14** strain is heavily researched for its ability to colonize the vaginal tract and prevent urinary tract infections (UTIs) and bacterial vaginosis.
### Enterococcus faecalis (EC-12) Found in specialized supplements (such as those from DHC), *E. faecalis* is often utilized in a sterilized, heat-killed format. Because the bacteria are small and dead, massive quantities (trillions of cells) can be packed into a single small dose, providing a powerful stimulus to the gut's immune tissue without the risk of bacterial overgrowth.
## Live vs. Heat-Killed (Postbiotic) Bacteria
A common myth in the probiotic space is that bacteria must be alive to be effective. While live cultures are necessary for true colonization and ongoing lactic acid production, modern research has revealed the power of "postbiotics" or heat-killed bacteria.
For example, Examine.com highlights that for the reduction of *H. pylori*, heat-killed cultures like **Pylopass™ (DSMZ 17648)** are just as effective as live cultures. The dead bacterial cells still possess the specific surface structures required to bind to and neutralize *H. pylori*, allowing it to be flushed from the stomach. Heat-killed LAB offer significant advantages in product formulation, as they are entirely shelf-stable, do not require refrigeration, and can be subjected to the high heat of manufacturing processes.
## Delivery Systems and Bioavailability
The stomach is designed to destroy bacteria—its highly acidic environment is the body's first line of defense against foodborne illness. Therefore, for live LAB to be effective, they must survive gastric transit.
Manufacturers use several techniques to ensure bioavailability: 1. **Microencapsulation:** Strains like NCIMB 30242 are often microencapsulated. This protective lipid or polymer coating shields the bacteria from stomach acid, dissolving only when it reaches the more neutral pH of the intestines. 2. **Overages:** Many brands formulate their products with massive "overages" (e.g., putting 50 billion CFUs in a capsule to ensure 10 billion survive to the expiration date). 3. **Alternative Delivery:** LAB can be delivered via chewing gum (to colonize the oral cavity for dental health) or naturally through fermented foods like sourdough bread.
## Dosage, Safety, and Side Effects
Lactic Acid Bacteria are generally recognized as safe (GRAS) and are well-tolerated by the vast majority of the population. The Mayo Clinic recommends a standard oral dosage of 1 capsule daily for maintaining a healthy stomach and intestines, though clinical doses can range from 1 billion to over 50 billion Colony Forming Units (CFUs) depending on the condition being treated.
Side effects are rare but can include mild, temporary digestive upset, such as gas or bloating, during the first few days of use as the gut microbiome adjusts. LAB supplements should be used with caution or avoided entirely by individuals who are severely immunocompromised, have central venous catheters, or suffer from severe acute pancreatitis, as there is a small risk of the bacteria translocating into the bloodstream and causing infection.
When choosing a LAB supplement, look for products that specify the exact strain (e.g., *L. acidophilus NCFM* rather than just *L. acidophilus*), guarantee the CFU count at the time of expiration, and utilize appropriate packaging (like blister packs or desiccant-lined bottles) to protect the bacteria from moisture and heat.